Immunai Acquires Swiss Company Nebion To Expand Its Platform for Target Discovery and Drug Development
The company welcomes the Nebion team, Moderna co-founder Robert Langer as a Board Member, and world-renowned immunologist Jacques Banchereau as incoming CSO Immunai, a New York and Tel Aviv-based biotech company, announced its acquisition of…